Plan: OPEN | Option: Growth | Meeta Shetty

18 Mar 24 | 12:00 AM

24.57 0.17 (0.71%)

  • Underperforms

    58.13%

    Return (1Y)

    underperformed Nifty Pharma TRI by -4.03%

  • Less Volatile

    0.70%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.12%

  • Not so consistent

    4/12

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • Tata India Pharma & Healthcare Fund (G) fund has been the 4th best in 5Y performance in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been given the 6th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been the 3rd best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (G), has beaten by -4.03% (CAGR difference)

58.13%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (G) is Lower than by -0.12%

0.70%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 4 out of Last 12 Months, i.e 33.33% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition